Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)—Polish compassionate use experience

Recent developments in the field of targeted therapy have led to the discovery of a new drug, plerixafor, that is a specific inhibitor of the CXCR4 receptor. Plerixafor acts in concert with granulocyte colony-stimulating factor (G-CSF) to increase the number of stem cells circulating in the peripher...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Basak, Grzegorz Wladyslaw, Knopinska-Posluszny, Wanda, Matuszak, Magdalena, Kisiel, Elzbieta, Hawrylecka, Dorota, Szmigielska-Kaplon, Anna, Urbaniak-Kujda, Donata, Dybko, Jaroslaw, Zielinska, Patrycja, Dabrowska-Iwanicka, Anna, Werkun, Joanna, Rzepecki, Piotr, Wroblewska, Wiktoria, Wiktor-Jedrzejczak, Wieslaw
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3070880/
https://ncbi.nlm.nih.gov/pubmed/20938660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-010-1098-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados